Dr. Sumit Subudhi

0:33:10

Prostate Cancer Immunotherapy with Dr. Sumit Subudhi

1:10:02

PCL #66 Update-Immunotherapies for Metastatic Castrate Resistant Prostate Cancer (Sumit Subudhi)

0:01:31

Dr Sumit Subudhi Discusses Immune Checkpoint Inhibitors in Prostate Cancer

0:05:40

Sumit K. Subudhi, MD, PhD, on Results from the Phase 2 CheckMate 650 Trial

0:01:56

Dr. Subudhi Discusses Rationale for CheckMate-650 Study in Prostate Cancer

0:00:45

Sumit K. Subudhi, MD, PhD, considers the outcomes of the KEYNOTE 365 study

0:00:58

Sumit K. Subudhi, MD, PhD, on when sipuleucel-T should be used in treatment of mCRPC

0:49:28

Immunotherapies for Prostate, Bladder, and Kidney Cancers, with Sumit Subudhi

0:02:12

ASCO GU 2019 - Dr. Sumit K Subudhi, MD Anderson, USA

0:00:42

Sumit K. Subudhi, MD, PhD, discusses combining checkpoint inhibitors in mCRPC

0:04:10

Prostate Cancer: How to Know If Your Treatment Plan Is Working

0:04:51

What Prostate Cancer Research Is Showing Promise?

0:28:58

Clinical Trials as a Prostate Cancer Treatment Option | What You Should Know

0:05:20

Prostate Cancer Clinical Trial Safety and Protocols

0:02:44

How to Become a Partner in Your Own Prostate Cancer Care

0:05:46

Overcoming Barriers to Quality Prostate Cancer Care

0:02:43

Why Prostate Cancer Patients Should Consider Participating in a Clinical Trial

0:03:08

Targeted Prostate Cancer Therapies vs. Chemotherapy: What’s the Difference?

0:03:15

What Should Prostate Cancer Patients Know About Clinical Trials?

0:05:33

Prostate Cancer Testing: What Tests Should You Advocate For?

0:08:41

Understanding Prostate Cancer Clinical Trial Phases and Types

0:59:37

Keynote Presentation: Development of Rational Immunotherapy Combinations to Overcome the Immuno...

0:03:04

The Link Between Prostate Cancer and Inherited Mutations

0:58:45

A Unique Personalized Killer T-cell Treatment for Glioblastoma - Wayne Carter, DVM, PhD